Incarvillea delavayi
Incarvillea delavayi · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Incarvillea delavayi is a botanical species known for its diverse pharmacological potential and therapeutic properties. Recent scientific investigations have focused on various preparations, including the MeOH extract, the delavayi extract, and the whole plant. These studies specifically highlight the antinociceptive activities associated with the plant's chemical composition. Key bioactive compounds identified within these extracts include 8-Epideoxyloganic acid and Delavayiine A. Understanding these chemical constituents provides valuable insight into the plant's ability to modulate pain responses.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Bignoniaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Incarvillea delavayi is a remarkable plant known by a variety of descriptive common names across different regions. It is frequently referred to as the Chinese trumpet-flower due to the distinctive shape of its blooms. Gardeners may also recognize it by the elegant moniker Hardy Gloxinia. In certain linguistic contexts, it is identified as dvojostice Delavayova or inkarvilea Delavayova. Finally, the species is sometimes documented as incarvillée de Delavay, reflecting its diverse botanical identity.
Sources: Catalogue of Life (COL)
Taxonomy
Incarvillea delavayi is a distinctive member of the kingdom Plantae. Within this vast biological kingdom, the species is classified under the class Equisetopsida. It belongs to the order Lamiales, showcasing its specific evolutionary lineage. This plant is further nested within the family Bignoniaceae, a group known for its diverse floral structures. Ultimately, it is identified by its unique placement within the genus Incarvillea.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Bignoniaceae |
| Genus | Incarvillea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Incarvillea delavayi is a striking plant primarily distributed throughout the temperate regions of Asia. It is most notably found thriving in the diverse landscapes of China, where it plays a role in the local flora. Within the country, its presence is particularly concentrated in the South-Central provinces. This specific geographic range highlights the unique environmental requirements necessary for its successful growth. Understanding these distribution patterns is essential for anyone studying the botanical heritage of the region.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Incarvillea delavayi is a self-supporting plant that maintains its own structural integrity without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Incarvillea delavayi has demonstrated notable antinociceptive activity through various studies involving its chemical constituents. Research utilizing the acetic acid-induced writhing test in mice reveals that extracts from the plant can decrease pain-related behaviors in a dose-dependent manner. While the compound 8-epideoxyloganic acid shows only weak effects when administered orally, it fails to produce significant results via subcutaneous injection. In contrast, the novel monoterpene alkaloid delavayine A exhibits a much more significant level of antinociceptive activity when injected subcutaneously. These findings highlight the potential of specific bioactive compounds within the plant for managing pain.
Compounds
Incarvillea delavayi serves as a rich source of bioactive compounds that demonstrate notable pharmacological potential. Specifically, this plant contains 8-epideoxyloganic acid, which has been observed to exhibit weak antinociceptive activity when administered orally. Additionally, the species contains delavayine A, a novel monoterpene alkaloid found within its chemical profile. Research indicates that while 8-epideoxyloganic acid's effectiveness is limited, delavayine A shows a more significant level of antinociceptive activity when injected subcutaneously. These findings highlight the importance of the specific chemical constituents found within Incarvillea delavayi for pain management studies.
Conditions
Incarvillea delavayi possesses antinociceptive properties that can effectively treat the acetic acid induced writhing test in mice. When administered orally, the plant extract demonstrates a dose-dependent ability to decrease the frequency of writhings and stretchings. The constituent 8-epideoxyloganic acid also shows weak antinociceptive activity when taken orally, though it lacks effectiveness via subcutaneous injection. In contrast, the novel monoterpene alkaloid delavayin A provides a much more significant level of relief when administered through subcutaneous injection. These findings highlight the varying therapeutic potentials of different components found within the plant.
Preparations
Incarvillea delavayi is prepared as a MeOH extract to isolate novel actinidine-type monoterpene alkaloids like delavayines B and C. The plant is also prepared as a delavayi extract to evaluate its antinociceptive activities through substances like 8-epideoxyloganic acid. Research further utilizes Incarvillea delavayi prepared as an extract to test dose-dependent effects on mouse writhing responses. Additionally, the species is prepared as the whole plant to facilitate the isolation of triterpenoid saponins and monoterpenoid glycosides. These various preparation methods allow for the identification of specific chemical constituents such as incarvillosides.